SUBSCRIBE
SUBSCRIBE

BioSpace Insights

The BioSpace Insights team performs research and analysis on industry trends for BioSpace and clients, producing industry reports, podcasts, events and articles.

Business
51%: The Untapped Market
In this episode of Denatured, BioSpace’s Head of Insights Lori and guests from Teva Pharmaceuticals and TOWER Capital Group discuss how critical it is to incorporate women into leadership positions and board rooms as a sound investment strategy.
November 21, 2024
 · 
1 min read
 · 
Lori Ellis
Business
Investing in AI: Benefits, Regulatory Challenges
In this episode of Denatured, BioSpace’s Head of Insights Lori and guests from Teva Pharmaceuticals and TOWER Capital discuss the opportunities, regulatory challenges and uncertainty surrounding AI.
November 7, 2024
 · 
1 min read
 · 
Lori Ellis
Photo of Johns Hopkins biomedical engineering students at work against grid background
Partnered
From Theory to Practice: Johns Hopkins Design Team Sets Undergrads Up for Success
At Johns Hopkins University, the biomedical engineering program’s Design Team offering lets undergraduates dive deep into clinical projects that can help them land industry jobs, get provisional patents or even start companies.
November 6, 2024
 · 
6 min read
 · 
BioSpace Insights
Career Advice
Webinar: Breaking into Biotech
This webinar will help you discover effective strategies for launching your career in biotechnology. You will gain valuable insights from industry experts and leave with the essential tools you need to thrive in this dynamic field.
October 29, 2024
 · 
1 min read
 · 
BioSpace Insights
Business
Steady But Slow: Future Outlook For Investment
In this episode of Denatured, Lori and guests from Teva Pharmaceuticals and TOWER Capital review the investment landscape this year and the policies influencing investment heading into 2025.
October 24, 2024
 · 
1 min read
 · 
Lori Ellis
News
Webinar: Revolutionizing Biologics Discovery: Harnessing the Power of AI and Patent Data
This webinar explores the pivotal role of patent data in overcoming the data challenges faced by generative AI models in drug discovery, particularly for biologics. Watch now.
October 23, 2024
 · 
1 min read
 · 
BioSpace Insights
Employer Resources
Report: Employer Branding: What Matters to Life Sciences Candidates
October 22, 2024
 · 
1 min read
 · 
BioSpace Insights
Illustration featuring image of USP expert volunteers
Partnered
USP Aims to Double, Diversify Volunteer Applicant Pool for 2025–2030 Cycle
United States Pharmacopeia is recruiting expert volunteers from academia, industry, regulatory and healthcare to develop, revise and approve medicine, dietary supplement and food ingredient standards and solutions used in more than 150 countries to improve global public health. The volunteers will serve from 2025 to 2030.
October 21, 2024
 · 
5 min read
 · 
BioSpace Insights
Drug Development
How AI Could Ease Tension in Clinical Trials
In the third episode of our mini series on artificial intelligence, Lori and guests continue their exploratory discussion on AI and the opportunity in patient lives.
October 10, 2024
 · 
1 min read
 · 
Lori Ellis
VIP Event at the Bioprocessing Summing 2024
Business
The White House, Microsoft, SAS, Foley Hoag & Astellas Offer AI Guidance to Investors. Part Two: The Future
As technology continues to evolve, companies should have strategies that incorporate an understand of where they are now, where they want to be, and do they have the talent to get there.
September 24, 2024
 · 
6 min read
 · 
Lori Ellis
From Left to right: Lori Ellis, Sherrine Eid, Colin Zick, Nagisa Sakurai, Mike Walker, Sarah Glaven
Business
The White House, Microsoft, SaS, Foley Hoag & Astellas Offer AI Guidance to Investors. Part One: The Present
Before companies and investors look towards the future, they must first understand the opportunities and challenges AI presents to them. From the benefits included in advancing processes to cybersecurity hazards, AI innovation is a balanced scale of oppportunities and risks.
September 23, 2024
 · 
10 min read
 · 
Lori Ellis
News
Video Recap - Regulatory Agility: The Intersection of AI and QARA
August 20, 2024
 · 
1 min read
 · 
BioSpace Insights
Rajesh Misra, Principal, Life Sciences Quality and Regulatory, KPMG; Denise Mead, Healthcare and Life Sciences Technology Leader, Microsoft; Don Soong, Sr. Director/GM, QARA and Spend Transparency Solutions, IQVIA
Partnered
QARA Professionals Question a Future with Cybersecurity Issues, US Litigation, and the EU AI Act
At a private event held amid the fallout from the CrowdStrike incident, cybersecurity issues took a front seat, with the consequences of the evolving EU AI Act and the Loper Bright and Corner Post decisions also raising concerns for quality assurance and regulatory affairs professionals.
August 12, 2024
 · 
8 min read
 · 
BioSpace Insights
Drug Development
Positioning QARA as a Market Access Function in Globalization
In this live panel discussion, speakers focused on the EU AI Act’s global regulatory implications for medical devices & QARA’s future. An executive summary is available.
August 6, 2024
 · 
1 min read
 · 
Lori Ellis
Drug Development
The Benefits of a Connected Quality & Regulatory Ecosystem
In this live panel discussion, speakers navigate integrated ecosystems and the future of QARA. An executive summary is available.
August 6, 2024
 · 
1 min read
 · 
Lori Ellis
Load More